Ifp Advisors, Inc Bio Cardia, Inc. Transaction History

Ifp Advisors, Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Sep 06, 2022	BUY	$17.7 - $32.55 $1,770 - $3,254	100 New	100 $1,000
Q2 2022 Aug 12, 2022	SELL	$17.7 - $32.55 $1,770 - $3,254	-100 Closed	0 $0
Q1 2022 Sep 06, 2022	BUY	$21.3 - $39.0 $2,130 - $3,900	100 New	100 $0

Ticker BCDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,758,200
Market Cap $39.8M
Description
BioCardia, Inc., a clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases. Its lead therapeutic candidate is the CardiAMP Cell Therapy System for the treatment of heart failure and chronic myocardial ischemia; and allogeneic cell therapy for cardiac and pulmonary di...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.